Skip to main content
Top
Published in: Neurosurgical Review 1/2024

01-12-2024 | Metastasis | Review

Prediction of the treatment response and local failure of patients with brain metastasis treated with stereotactic radiosurgery using machine learning: A systematic review and meta-analysis

Authors: Mohammad Amin Habibi, Farhang Rashidi, Adriana Habibzadeh, Ehsan Mehrtabar, Mohammad Reza Arshadi, Mohammad Sina Mirjani

Published in: Neurosurgical Review | Issue 1/2024

Login to get access

Abstract

Background

Stereotactic radiosurgery (SRS) effectively treats brain metastases. It can provide local control, symptom relief, and improved survival rates, but it poses challenges in selecting optimal candidates, determining dose and fractionation, monitoring for toxicity, and integrating with other modalities. Practical tools to predict patient outcomes are also needed. Machine learning (ML) is currently used to predict treatment outcomes. We aim to investigate the accuracy of ML in predicting treatment response and local failure of brain metastasis treated with SRS.

Methods

PubMed, Scopus, Web of Science (WoS), and Embase were searched until April 16th, which was repeated on October 17th, 2023 to find possible relevant papers. The study preparation adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline. The statistical analysis was performed by the MIDAS package of STATA v.17.

Results

A total of 17 articles were reviewed, of which seven and eleven were related to the clinical use of ML in predicting local failure and treatment response. The ML algorithms showed sensitivity and specificity of 0.89 (95% CI: 0.84–0.93) and 0.87 (95% CI: 0.81–0.92) for predicting treatment response. The positive likelihood ratio was 7.1 (95% CI: 4.5–11.1), the negative likelihood ratio was 0.13 (95% CI: 0.08–0.19), and the diagnostic odds ratio was 56 (95% CI: 25–125). Moreover, the pooled estimates for sensitivity and specificity of ML algorithms for predicting local failure were 0.93 (95% CI: 0.76–0.98) and 0.80 (95% CI: 0.53–0.94). The positive likelihood ratio was 4.7 (95% CI: 1.6–14.0), the negative likelihood ratio was 0.09 (95% CI: 0.02–0.39), and the diagnostic odds ratio was 53 (95% CI: 5-606).

Conclusion

ML holds promise in predicting treatment response and local failure in brain metastasis patients receiving SRS. However, further studies and improvements in the treatment process can refine the models and effectively integrate them into clinical practice.
Appendix
Available only for authorised users
Literature
2.
go back to reference Sperduto PW et al (2020) Survival in patients with brain metastases: Summary Report on the updated diagnosis-specific graded Prognostic Assessment and Definition of the eligibility quotient. J Clin Oncol 38(32):3773–3784CrossRefPubMedPubMedCentral Sperduto PW et al (2020) Survival in patients with brain metastases: Summary Report on the updated diagnosis-specific graded Prognostic Assessment and Definition of the eligibility quotient. J Clin Oncol 38(32):3773–3784CrossRefPubMedPubMedCentral
3.
go back to reference Steindl A et al (2020) Neurological symptom burden impacts survival prognosis in patients with newly diagnosed non-small cell lung cancer brain metastases. Cancer 126(19):4341–4352CrossRefPubMed Steindl A et al (2020) Neurological symptom burden impacts survival prognosis in patients with newly diagnosed non-small cell lung cancer brain metastases. Cancer 126(19):4341–4352CrossRefPubMed
4.
go back to reference Wu A, Colón GR, Lim M (2022) Quality of life and role of Palliative and supportive care for patients with brain metastases and caregivers: a review. Front Neurol 13:806344CrossRefPubMedPubMedCentral Wu A, Colón GR, Lim M (2022) Quality of life and role of Palliative and supportive care for patients with brain metastases and caregivers: a review. Front Neurol 13:806344CrossRefPubMedPubMedCentral
5.
go back to reference Badiyan SN, Regine WF, Mehta M (2016) Stereotactic radiosurgery for treatment of Brain metastases. J Oncol Pract 12(8):703–712CrossRefPubMed Badiyan SN, Regine WF, Mehta M (2016) Stereotactic radiosurgery for treatment of Brain metastases. J Oncol Pract 12(8):703–712CrossRefPubMed
6.
go back to reference Yan M et al (2023) Hypofractionated stereotactic radiosurgery (HSRS) as a salvage treatment for brain metastases failing prior stereotactic radiosurgery (SRS). J Neurooncol 162(1):119–128CrossRefPubMed Yan M et al (2023) Hypofractionated stereotactic radiosurgery (HSRS) as a salvage treatment for brain metastases failing prior stereotactic radiosurgery (SRS). J Neurooncol 162(1):119–128CrossRefPubMed
9.
go back to reference Mantovani C et al (2021) Modern Radiation Therapy for the management of Brain metastases from Non-small Cell Lung Cancer: current approaches and future directions. Front Oncol 11:772789CrossRefPubMedPubMedCentral Mantovani C et al (2021) Modern Radiation Therapy for the management of Brain metastases from Non-small Cell Lung Cancer: current approaches and future directions. Front Oncol 11:772789CrossRefPubMedPubMedCentral
10.
go back to reference Habibi MA et al (2024) The safety and efficacy of dabrafenib and trametinib in patients with glioma: a systematic review and meta-analysis. European Journal of Clinical Pharmacology Habibi MA et al (2024) The safety and efficacy of dabrafenib and trametinib in patients with glioma: a systematic review and meta-analysis. European Journal of Clinical Pharmacology
11.
go back to reference Stankiewicz M, Tomasik B, Blamek S (2021) A new prognostic score for predicting survival in patients treated with robotic stereotactic radiotherapy for brain metastases. Sci Rep 11(1):20347CrossRefPubMedPubMedCentral Stankiewicz M, Tomasik B, Blamek S (2021) A new prognostic score for predicting survival in patients treated with robotic stereotactic radiotherapy for brain metastases. Sci Rep 11(1):20347CrossRefPubMedPubMedCentral
13.
go back to reference Habibi MA et al (2023) The performance of machine learning for prediction of H3K27 M mutation in midline gliomas: a systematic review and Meta-analysis. World Neurosurgery Habibi MA et al (2023) The performance of machine learning for prediction of H3K27 M mutation in midline gliomas: a systematic review and Meta-analysis. World Neurosurgery
14.
go back to reference Habibi MA et al (2024) Predicting the radiological outcome of cerebral aneurysm treatment with machine learning algorithms; a systematic review and diagnostic meta-analysis. Interdisciplinary Neurosurg 36:101929CrossRef Habibi MA et al (2024) Predicting the radiological outcome of cerebral aneurysm treatment with machine learning algorithms; a systematic review and diagnostic meta-analysis. Interdisciplinary Neurosurg 36:101929CrossRef
15.
go back to reference Habibi MA et al (2024) Prediction of cerebral aneurysm rupture risk by machine learning algorithms: a systematic review and meta-analysis of 18,670 participants. Neurosurg Rev 47(1):34CrossRefPubMed Habibi MA et al (2024) Prediction of cerebral aneurysm rupture risk by machine learning algorithms: a systematic review and meta-analysis of 18,670 participants. Neurosurg Rev 47(1):34CrossRefPubMed
16.
go back to reference Shahidi R et al (2023) Diagnostic performance of MRI radiomics for classification of Alzheimer’s disease, mild cognitive impairment, and normal subjects: a systematic review and meta-analysis. Aging Clin Exp Res 35(11):2333–2348CrossRefPubMed Shahidi R et al (2023) Diagnostic performance of MRI radiomics for classification of Alzheimer’s disease, mild cognitive impairment, and normal subjects: a systematic review and meta-analysis. Aging Clin Exp Res 35(11):2333–2348CrossRefPubMed
17.
go back to reference Lin YY et al (2023) Application of artificial intelligence to stereotactic radiosurgery for intracranial lesions: detection, segmentation, and outcome prediction. J Neurooncol 161(3):441–450CrossRefPubMed Lin YY et al (2023) Application of artificial intelligence to stereotactic radiosurgery for intracranial lesions: detection, segmentation, and outcome prediction. J Neurooncol 161(3):441–450CrossRefPubMed
19.
go back to reference Whiting PF et al (2011) QUADAS-2: a revised Tool for the Quality Assessment of Diagnostic Accuracy studies. Ann Intern Med 155(8):529–536CrossRefPubMed Whiting PF et al (2011) QUADAS-2: a revised Tool for the Quality Assessment of Diagnostic Accuracy studies. Ann Intern Med 155(8):529–536CrossRefPubMed
20.
go back to reference Jaberipour M et al (2021) A priori prediction of local failure in brain metastasis after hypo-fractionated stereotactic radiotherapy using quantitative MRI and machine learning. Sci Rep, 11(1) Jaberipour M et al (2021) A priori prediction of local failure in brain metastasis after hypo-fractionated stereotactic radiotherapy using quantitative MRI and machine learning. Sci Rep, 11(1)
21.
go back to reference Jaberipour M et al (2020) Predicting Local failure after Stereotactic Radiation Therapy in Brain Metastasis using quantitative CT and machine learning(). Annu Int Conf IEEE Eng Med Biol Soc 2020:1323–1326PubMed Jaberipour M et al (2020) Predicting Local failure after Stereotactic Radiation Therapy in Brain Metastasis using quantitative CT and machine learning(). Annu Int Conf IEEE Eng Med Biol Soc 2020:1323–1326PubMed
22.
go back to reference Wang H et al (2021) Predicting local failure of brain metastases after stereotactic radiosurgery with radiomics on planning MR images and dose maps. Med Phys 48(9):5522–5530CrossRefPubMed Wang H et al (2021) Predicting local failure of brain metastases after stereotactic radiosurgery with radiomics on planning MR images and dose maps. Med Phys 48(9):5522–5530CrossRefPubMed
23.
go back to reference Azimi P, Shahzadi S, Sadeghi S (2020) Use of artificial neural networks to predict the probability of developing new cerebral metastases after radiosurgery alone, vol 64. JOURNAL OF NEUROSURGICAL SCIENCES, pp 52–57. 1 Azimi P, Shahzadi S, Sadeghi S (2020) Use of artificial neural networks to predict the probability of developing new cerebral metastases after radiosurgery alone, vol 64. JOURNAL OF NEUROSURGICAL SCIENCES, pp 52–57. 1
24.
go back to reference Buzea CG et al (2023) AI evaluation of imaging factors in the evolution of stage-treated metastases using Gamma Knife. Diagnostics (Basel), 13(17). Buzea CG et al (2023) AI evaluation of imaging factors in the evolution of stage-treated metastases using Gamma Knife. Diagnostics (Basel), 13(17).
25.
go back to reference Moon HC, Park YS (2022) Volume prediction for large brain metastases after hypofractionated gamma knife radiosurgery through artificial neural network. Med (United States) 101(40):E30964 Moon HC, Park YS (2022) Volume prediction for large brain metastases after hypofractionated gamma knife radiosurgery through artificial neural network. Med (United States) 101(40):E30964
26.
go back to reference Rodrigues G et al (2014) A clinical nomogram and recursive partitioning analysis to determine the risk of regional failure after radiosurgery alone for brain metastases. Radiother Oncol 111(1):52–58CrossRefPubMed Rodrigues G et al (2014) A clinical nomogram and recursive partitioning analysis to determine the risk of regional failure after radiosurgery alone for brain metastases. Radiother Oncol 111(1):52–58CrossRefPubMed
27.
go back to reference Cha YJ et al (2018) Prediction of response to stereotactic radiosurgery for brain metastases using convolutional neural networks. Anticancer Res 38(9):5437–5445CrossRefPubMed Cha YJ et al (2018) Prediction of response to stereotactic radiosurgery for brain metastases using convolutional neural networks. Anticancer Res 38(9):5437–5445CrossRefPubMed
29.
go back to reference Kawahara D et al (2021) Predicting the local response of metastatic brain tumor to Gamma Knife Radiosurgery by Radiomics with a machine learning method. Front Oncol, 10 Kawahara D et al (2021) Predicting the local response of metastatic brain tumor to Gamma Knife Radiosurgery by Radiomics with a machine learning method. Front Oncol, 10
30.
go back to reference Du P et al (2023) Prediction of treatment response in patients with brain metastasis receiving stereotactic radiosurgery based on pre-treatment multimodal MRI radiomics and clinical risk factors: a machine learning model. Front Oncol 13:1114194CrossRefPubMedPubMedCentral Du P et al (2023) Prediction of treatment response in patients with brain metastasis receiving stereotactic radiosurgery based on pre-treatment multimodal MRI radiomics and clinical risk factors: a machine learning model. Front Oncol 13:1114194CrossRefPubMedPubMedCentral
31.
go back to reference Mouraviev A et al (2020) Use of radiomics for the prediction of local control of brain metastases after stereotactic radiosurgery. Neurooncology 22(6):797–805 Mouraviev A et al (2020) Use of radiomics for the prediction of local control of brain metastases after stereotactic radiosurgery. Neurooncology 22(6):797–805
32.
go back to reference Gutsche R et al (2022) Radiomics outperforms semantic features for prediction of response to stereotactic radiosurgery in brain metastases: Radiomics for response prediction to stereotactic radiosurgery. Radiother Oncol 166:37–43CrossRefPubMed Gutsche R et al (2022) Radiomics outperforms semantic features for prediction of response to stereotactic radiosurgery in brain metastases: Radiomics for response prediction to stereotactic radiosurgery. Radiother Oncol 166:37–43CrossRefPubMed
33.
go back to reference Jiang Z et al (2022) Multimodality MRI-based radiomics approach to predict the posttreatment response of lung cancer brain metastases to gamma knife radiosurgery. Eur Radiol 32(4):2266–2276CrossRefPubMed Jiang Z et al (2022) Multimodality MRI-based radiomics approach to predict the posttreatment response of lung cancer brain metastases to gamma knife radiosurgery. Eur Radiol 32(4):2266–2276CrossRefPubMed
34.
go back to reference Du P et al (2023) Development and validation of a radiomics-based prediction pipeline for the response to stereotactic radiosurgery therapy in brain metastases. Eur Radiol 33(12):8925–8935CrossRefPubMed Du P et al (2023) Development and validation of a radiomics-based prediction pipeline for the response to stereotactic radiosurgery therapy in brain metastases. Eur Radiol 33(12):8925–8935CrossRefPubMed
35.
go back to reference DeVries DA et al (2023) Dual-center validation of using magnetic resonance imaging radiomics to predict stereotactic radiosurgery outcomes. Neurooncol Adv 5(1):vdad064PubMedPubMedCentral DeVries DA et al (2023) Dual-center validation of using magnetic resonance imaging radiomics to predict stereotactic radiosurgery outcomes. Neurooncol Adv 5(1):vdad064PubMedPubMedCentral
36.
go back to reference Mulford K et al (2021) A radiomics-based model for predicting local control of resected brain metastases receiving adjuvant SRS. Clin Translational Radiation Oncol 29:27–32CrossRef Mulford K et al (2021) A radiomics-based model for predicting local control of resected brain metastases receiving adjuvant SRS. Clin Translational Radiation Oncol 29:27–32CrossRef
37.
go back to reference Chao ST et al (2018) Stereotactic radiosurgery in the management of limited (1–4) brain metasteses: systematic review and international stereotactic radiosurgery society practice guideline. Neurosurgery 83(3):345–353CrossRefPubMed Chao ST et al (2018) Stereotactic radiosurgery in the management of limited (1–4) brain metasteses: systematic review and international stereotactic radiosurgery society practice guideline. Neurosurgery 83(3):345–353CrossRefPubMed
38.
go back to reference Minniti G et al (2016) Single-fraction versus multifraction (3× 9 Gy) stereotactic radiosurgery for large (> 2 cm) brain metastases: a comparative analysis of local control and risk of radiation-induced brain necrosis. Int J Radiation Oncology* Biology* Phys 95(4):1142–1148CrossRef Minniti G et al (2016) Single-fraction versus multifraction (3× 9 Gy) stereotactic radiosurgery for large (> 2 cm) brain metastases: a comparative analysis of local control and risk of radiation-induced brain necrosis. Int J Radiation Oncology* Biology* Phys 95(4):1142–1148CrossRef
39.
go back to reference Tsao M, Xu W, Sahgal A (2012) A meta-analysis evaluating stereotactic radiosurgery, whole‐brain radiotherapy, or both for patients presenting with a limited number of brain metastases. Cancer 118(9):2486–2493CrossRefPubMed Tsao M, Xu W, Sahgal A (2012) A meta-analysis evaluating stereotactic radiosurgery, whole‐brain radiotherapy, or both for patients presenting with a limited number of brain metastases. Cancer 118(9):2486–2493CrossRefPubMed
40.
go back to reference Galldiks N et al (2020) Imaging challenges of immunotherapy and targeted therapy in patients with brain metastases: response, progression, and pseudoprogression. Neurooncology 22(1):17–30 Galldiks N et al (2020) Imaging challenges of immunotherapy and targeted therapy in patients with brain metastases: response, progression, and pseudoprogression. Neurooncology 22(1):17–30
41.
go back to reference Abouei Mehrizi MA et al (2023) The safety and efficacy of eCLIPs for treatment of wide-necked bifurcation aneurysms: a systematic review and Meta-analysis. World Neurosurg 180:213–223e7CrossRefPubMed Abouei Mehrizi MA et al (2023) The safety and efficacy of eCLIPs for treatment of wide-necked bifurcation aneurysms: a systematic review and Meta-analysis. World Neurosurg 180:213–223e7CrossRefPubMed
43.
go back to reference Paybast S, Habibi MA, Naser Moghadasi A (2023) Characteristics and management of multiple sclerosis patients during the Omicron era: is there a concern about the MS course in the face of the new variant of COVID-19? Neurol Sci 44(2):659–665CrossRefPubMed Paybast S, Habibi MA, Naser Moghadasi A (2023) Characteristics and management of multiple sclerosis patients during the Omicron era: is there a concern about the MS course in the face of the new variant of COVID-19? Neurol Sci 44(2):659–665CrossRefPubMed
44.
go back to reference Karalis VD (2024) The Integration of Artificial Intelligence into Clinical Practice. Appl Biosci 3(1):14–44CrossRef Karalis VD (2024) The Integration of Artificial Intelligence into Clinical Practice. Appl Biosci 3(1):14–44CrossRef
45.
go back to reference Hofer IS et al (2020) Realistically integrating machine learning into clinical practice: a Road Map of opportunities, challenges, and a potential future. Anesth Analg 130(5):1115–1118CrossRefPubMedPubMedCentral Hofer IS et al (2020) Realistically integrating machine learning into clinical practice: a Road Map of opportunities, challenges, and a potential future. Anesth Analg 130(5):1115–1118CrossRefPubMedPubMedCentral
46.
go back to reference Ed-Driouch C et al (2022) Addressing the challenges and barriers to the Integration of Machine Learning into clinical practice: an innovative method to Hybrid Human–Machine Intelligence. Sensors 22(21):8313CrossRefPubMedPubMedCentral Ed-Driouch C et al (2022) Addressing the challenges and barriers to the Integration of Machine Learning into clinical practice: an innovative method to Hybrid Human–Machine Intelligence. Sensors 22(21):8313CrossRefPubMedPubMedCentral
Metadata
Title
Prediction of the treatment response and local failure of patients with brain metastasis treated with stereotactic radiosurgery using machine learning: A systematic review and meta-analysis
Authors
Mohammad Amin Habibi
Farhang Rashidi
Adriana Habibzadeh
Ehsan Mehrtabar
Mohammad Reza Arshadi
Mohammad Sina Mirjani
Publication date
01-12-2024
Publisher
Springer Berlin Heidelberg
Published in
Neurosurgical Review / Issue 1/2024
Print ISSN: 0344-5607
Electronic ISSN: 1437-2320
DOI
https://doi.org/10.1007/s10143-024-02391-3

Other articles of this Issue 1/2024

Neurosurgical Review 1/2024 Go to the issue